Search - tctmd.com

Displaying 1 - 20 of 56

Sort: Relevancy | Date

News Conference News EuroPCR 2016

Sex Disparities in MI Care Are Narrowing, but There’s Still a Long Way to Go

Caitlin E. Cox

May 25, 2016

News Conference News EuroPCR 2016

Innovative Initiatives in Radiation Safety Lower Patient, Operator Dose in the Cath Lab

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Transradial PCI Shows Consistent Benefit in All ACS Patients: MATRIX Access

Michael O'Riordan

May 19, 2016

News Conference News EuroPCR 2016

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

Caitlin E. Cox

May 19, 2016

News Conference News EuroPCR 2016

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Michael O'Riordan

May 19, 2016

News Conference News EuroPCR 2016

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Yael L. Maxwell

May 19, 2016

News Conference News EuroPCR 2016

Of Hands and Hearts: Upper-Extremity Dysfunction Common Early After Transradial PCI

Michael O'Riordan

May 18, 2016

News Conference News EuroPCR 2016

From Italy to Bangladesh: STEMI Networks Matter

Caitlin E. Cox

May 18, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Conference News EuroPCR 2015

Preconditioning, Postconditioning Join Forces to Limit STEMI Damage

Caitlin E. Cox

May 22, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Conference News EuroPCR 2015

Positive Signs for OCT Guidance in PCI

Caitlin E. Cox

May 20, 2015

News Conference News EuroPCR 2015

CT-Derived FFR Alters Angiography-Based Management Plans for Stable Angina

Yael L. Maxwell

May 20, 2015

Presentation EuroPCR 2015

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

Presenter: Ota Hlinomaz

May 19, 2015

News Conference News EuroPCR 2015

PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI

Caitlin E. Cox

May 19, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Conference News EuroPCR 2015

DEFER at 15 Years: Postponing PCI Based on FFR in Stable Angina Lowers MI Risk

Yael L. Maxwell

May 19, 2015

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Yael L. Maxwell

May 23, 2014

Advertisement

Sex Disparities in MI Care Are Narrowing, but There’s Still a Long Way to Go

Innovative Initiatives in Radiation Safety Lower Patient, Operator Dose in the Cath Lab

Transradial PCI Shows Consistent Benefit in All ACS Patients: MATRIX Access

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Closer Look at Effects of CAD on TAVR Outcomes Unearths Grim Prognosis

Of Hands and Hearts: Upper-Extremity Dysfunction Common Early After Transradial PCI

From Italy to Bangladesh: STEMI Networks Matter

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Preconditioning, Postconditioning Join Forces to Limit STEMI Damage

Trials Explore the Potential of Biodegradable-Polymer Stents

Positive Signs for OCT Guidance in PCI

CT-Derived FFR Alters Angiography-Based Management Plans for Stable Angina

Multivessel Coronary Disease Diagnosed at the Time of Primary PCI for STEMI: Complete Revascularization Versus Conservative Strategy - PRAGUE 13 Trial

PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI

Evolving DES Technology May Benefit Diabetic Patients

DEFER at 15 Years: Postponing PCI Based on FFR in Stable Angina Lowers MI Risk

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content